With regard to the analysis of IFNγ levels in COVID-19 patients, transcript amounts for IFNγ were reduced in the lower respiratory tracts and PBMCs of critically ill patients compared to healthy donors despite all patients had negative results for plasma anti-IFNγ autoantibody detection. The gene discussed is IFNG; the disease is COVID-19.